In total, our work yielded a computational framework based on integrating CD8+ T cell-related genes, infiltration features of breast cancer chemoresistance-related TILCD8T cells, and clinical profile analysis to identify the specific expression patterns of chemoresistance-correlated TILCD8Ts (named “cr-TILCD8TSig”). The gene discussed is CD8A; the disease is breast carcinoma.